Nurocor
PrivateLast Round
Strategic
Jul 14, 2025
Total Funding Raised
$1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nurocor operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Strategic round in July 2025.
Nurocor is a life sciences technology company that provides a platform for digitalized clinical development to help organizations accelerate clinical trial lifecycles.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Workflow Automation, Data Governance, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nurocor Comparables
Compare Nurocor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Faro Health | 87% | |
| Certara | 81% | |
| eClinical Solutions | 78% |
For institutional investors. Book with your work email.
Nurocor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 14, 2025 | ||||
| VC Round | Oct 16, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nurocor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frontier Venture Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 38% MoM.
- Jul 20, 2026
Open roles increased to 28, 3.5x the trailing average.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 15, 2026
Nurocor, Inc's Nurocor Clinical Platform AI is now available as an AI-enabled clinical development platform with conversational agents, AI-assisted protocol ingestion, and intelligent study design workflows in Sep '26.
For institutional investors. Book with your work email.
Nurocor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nurocor's valuation, stock price, and market status.
Is Nurocor a public or private company?
Nurocor is a private company.
What is the current stock price of Nurocor?
Nurocor is a private company, so its shares have no public market price. Caplight tracks Nurocor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nurocor worth (valuation)?
Valuation information for Nurocor is not publicly available.
Can I buy Nurocor stock?
Nurocor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nurocor's last funding round?
Nurocor's most recent funding round was Strategic on July 14, 2025.
Who are the main investors in Nurocor?
Key investors in Nurocor include Frontier Venture Capital.
Will Nurocor IPO soon?
No public IPO plans have been announced for Nurocor.
How can I track Nurocor secondary market activity?
Caplight tracks bids, offers, and trades in Nurocor's shares on secondary markets.